A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : LRFS

Search Conditions:
Search Keyword : LRFS
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: LRFS
Appearance Frequency: 842 time(s)
Long forms: 16

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
local recurrence-free survival
(570 times)
Neoplasms
(376 times)
OS (351 times)
DMFS (160 times)
DFS (135 times)
1991 Prognostic factors for local control in nasopharyngeal cancer (NPC): analysis by multivariate proportional hazard models.
local relapse-free survival
(140 times)
Neoplasms
(101 times)
OS (104 times)
DMFS (72 times)
NPC (61 times)
1990 [The role of radiotherapy in the multimodal treatment of locally advanced breast carcinoma].
locoregional relapse-free survival
(89 times)
Neoplasms
(70 times)
OS (77 times)
DMFS (62 times)
PFS (43 times)
2005 Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis.
locoregional-free survival
(16 times)
Neoplasms
(9 times)
OS (12 times)
DMFS (6 times)
NPC (6 times)
2013 Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer.
LR-free survival
(10 times)
Neoplasms
(4 times)
LR (6 times)
LRR (4 times)
BCS (2 times)
2014 EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.
local relapse-free
(5 times)
Neoplasms
(4 times)
OS (3 times)
DFS (2 times)
MFS (2 times)
2007 Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
lateral neck recurrence-free survival
(2 times)
Neoplasms
(1 time)
PTC (2 times)
CI (1 time)
HR (1 time)
2017 Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
locoregional progression-free survival
(2 times)
Neoplasms
(1 time)
OS (2 times)
PFS (2 times)
ENI (1 time)
2020 Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China.
isolated-local recurrence free survival
(1 time)
Neoplasms
(1 time)
CR (1 time)
DLBCL (1 time)
OS (1 time)
2021 Emerging Role of Consolidative Radiotherapy After Complete Remission Following R-CHOP Immunochemotherapy in Stage III-IV Diffuse Large B-Cell Lymphoma: A Single Institutional and Case-Matched Control Study.
10  local failure-relapse-free survival
(1 time)
Therapeutics
(1 time)
GK (1 time)
NSCLC (1 time)
OS (1 time)
2015 Management of brain metastases from non-small cell lung cancer.
11  local recurrence progression- free survival
(1 time)
Therapeutics
(1 time)
HCSRT (1 time)
WBRT (1 time)
2013 Hypofractionated stereotactic radiotherapy in five daily fractions for post-operative surgical cavities in brain metastases patients with and without prior whole brain radiation.
12  Local recurrence-free survival in the standard group was significantly lower
(1 time)
Neoplasms
(1 time)
CI (1 time)
STS (1 time)
TM-ILP-group (1 time)
2020 Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities.
13  local relapse-free actuarial survival
(1 time)
Radiotherapy
(1 time)
CS (1 time)
1990 The Dijon clinical staging system for early rectal carcinomas amenable to intracavitary treatment techniques.
14  local RFS
(1 time)
Urologic Diseases
(1 time)
HD (1 time)
IQR (1 time)
KM (1 time)
2017 Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.
15  locoregional relapse-free
(1 time)
Radiotherapy
(1 time)
DMFS (1 time)
LRRC (1 time)
RFS (1 time)
2011 Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer.
16  LRFS rate and DFS rate than the high-ADC group
(1 time)
Neoplasms
(1 time)
ADC (1 time)
AUC (1 time)
DFS (1 time)
2019 The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.